Anti-CD44 monoclonal antibody inhibits heart transplant rejection mediated by alloantigen-primed CD4 memory T cells in nude mice

Immunological Investigations

Volumn 39, Issue 8, 2010, Pages 807-819

  Wang, Feng ^a   Chen, Jibing ^a   Shao, Wei ^a   Xie, Baiyi ^a   Wang, Yongzhi ^a   Lan, Tianshu ^a   Thorlacius, Henrik ^b   Qi, Zhongquan ^a  

^a XIAMEN UNIVERSITY   (China)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Anti CD44 mAb; Cardiac transplantation; CD4+ memory T cells

Indexed keywords

ALLOANTIGEN; CD44 MONOCLONAL ANTIBODY; CELL ADHESION MOLECULE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; MONOCLONAL ANTIBODY; RTK 4530; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARDIAC GRAFT REJECTION; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; FEMALE; GRAFT RECIPIENT; GRAFT SURVIVAL; HISTOLOGY; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SERUM; SURVIVAL TIME;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD44; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; IMMUNOLOGIC MEMORY; ISOANTIGENS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, NUDE; TRANSPLANTATION, HOMOLOGOUS;

EID: 77958165118     PISSN: 08820139     EISSN: 15324311     Source Type: Journal    
DOI: 10.3109/08820139.2010.497833     Document Type: Article

References (30)

1. Adamia, S., Maxwell, C. A., et al. (2005). Hyaluronan and hyaluronan synthases: Potential therapeutic targets in cancer. Curr. Drug Targets Cardiovasc. Haematol. Disord. 5:3-14.
2. Billingham, M. E., Cary, N. R., et al. (1990). A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. J. Heart Transplant. 9:587-593.
3. Bollyky, P. L., Falk, B. A., et al. (2009). CD44 costimulation promotes FoxP3+ regulatory T cell persistence and function via production of IL-2, IL-10, and TGF-beta. J. Immunol. 183:2232-2241.
4. Borland, G., Ross, J. A., et al. (1998). Forms and functions of CD44. Immunology 93:139-148.
5. Burrows, S. R., Khanna, R., et al. (1994). An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease. J. Exp. Med. 179:1155-1161.
6. Burrows, S. R., Silins, S. L., et al. (1997). Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity. Eur. J. Immunol. 27:1726-1736.
7. Dougherty, G. J., Landorp, P. M., et al. (1991). Molecular cloning of CD44R1 and CD44R2, two novel isoforms of the human CD44 lymphocyte "homing" receptor expressed by hemopoietic cells. J. Exp. Med. 174:1-5.
8. Goodison, S., Urquidi, V. et al. (1999). CD44 cell adhesion molecules. Mol. Pathol. 52:189-196.
9. Haudebourg, T., Poirier, N., et al. (2009). Depleting T-cell subpopulations in organ transplantation. Transpl. Int. 22:509-518.
10. Horst, D., Kriegl, L., et al. (2009). Prognostic significance of the cancer stem cell markers CD133, CD44, and CD166 in colorectal cancer. Cancer Invest. 1.
11. Huet, S., Groux, H., et al. (1989). CD44 contributes to T cell activation. J. Immunol. 143:798-801.
12. Jin, L., Hope, K. J., et al. (2006). Targeting of CD44 eradicates human acute myeloid leukemic stem cells. Nat. Med. 12:1167-1174.
13. Lakkis, F. G., Sayegh, M. H. (2003). Memory T cells: a hurdle to immunologic tolerance. J. Am. Soc. Nephrol. 14:2402-2410.
14. Liu, J., Jiang, G. (2006). CD44 and hematologic malignancies. Cell Mol. Immunol. 3:359-365.
15. Matsuura, A., Abe, T., et al. (1991). Simplified mouse cervical heart transplantation using a cuff technique. Transplantation 51:896-898.
16. Mbitikon-Kobo, F. M., Vocanson, M., et al. (2009). Characterization of a CD44/CD122int memory CD8 T cell subset generated under sterile inflammatory conditions. J. Immunol. 182:3846-3854.
17. Minamimura, K., Sato, K., et al. (2008). Strategies to induce marked prolongation of secondary skin allograft survival in alloantigen-primed mice. Am. J. Transplant. 8:761-772.
18. Ponta, H., Sherman, L., et al. (2003). CD44: from adhesion molecules to signalling regulators. Nat. Rev. Mol. Cell. Biol. 4:33-45.
19. Rajasagi, M., Vitacolonna, M., et al. (2009). CD44 promotes progenitor homing into the thymus and T cell maturation. J. Leukoc. Biol. 85:251-261.
20. Seiter, S., Weber, B., et al. (1998). Down-modulation of host reactivity by anti-CD44 in skin transplantation. Transplantation 66:778-791.
21. Shevach, E. M., Davidson, T. S., et al. (2008). Role of TGF-Beta in the induction of Foxp3 expression and T regulatory cell function. J. Clin. Immunol. 28:640-646.
22. Siegelman, M. H., DeGrendele, H. C., et al. (1999). Activation and interaction of CD44 and hyaluronan in immunological systems. J. Leukoc. Biol. 66:315-321.
23. Uchida, J., Lee, Y., et al. (2004). Mouse CD20 expression and function. Int. Immunol. 16:119-129.
24. Valujskikh, A., Lakkis, F. G. (2003). In remembrance of things past: memory T cells and transplant rejection. Immunol. Rev. 196:65-74.
25. Valujskikh, A., Li, X. C. (2007). Frontiers in nephrology: T cell memory as a barrier to transplant tolerance. J. Am. Soc. Nephrol. 18:2252-2261.
26. von Boehmer, H. (2005). Mechanisms of suppression by suppressor T cells. Nat. Immunol. 6:338-344.
27. Vu, M. D., Clarkson, M. R., et al. (2006). Critical, but conditional, role of OX40 in memory T cell-mediated rejection. J. Immunol. 176:1394-1401.
28. Winters, G. L., Marboe, C. C., et al. (1998). The International Society for Heart and Lung Transplantation grading system for heart transplant biopsy specimens: Clarification and commentary. J. Heart Lung Transplant. 17:754-760.
29. Wu, G. D., He, Y., et al. (2008). Anti-CD20 antibody suppresses anti-HLA antibody formation in a HLA-A2 transgenic mouse model of sensitization. Transpl. Immunol. 19:178-186.
30. Zoller, M., Fohr, N., et al. (1998). Treatment of mice with anti-CD44 after allogeneic bone marrow cell transplantation is lethal. J. Leukoc. Biol. 63:175-189.